• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全科医疗中第三次口服维生素K剂量的摄取情况。

The uptake of the third oral vitamin K dose in general practice.

作者信息

Hill R J

出版信息

N Z Med J. 1994 May 11;107(977):177-8.

PMID:8177574
Abstract

AIM

To assess the uptake of the third oral vitamin K dose in general practice.

METHOD

Infants born between 1 October 1992 and 4 February 1993 in the Rotorua area were identified. This included all infants born at the maternity unit and home births within the Rotorua area. The general practitioner recorded as the preferred primary healthcare provider was contacted and a questionnaire completed.

RESULTS

There were 521 recorded births. Of these 104 were excluded as they were non resident within the Rotorua area. Of those infants residing in Rotorua after birth (417), a further 77 were excluded due to: No general practitioner identified 3; deaths 3; transfers--outcome unknown 18; and intramuscular vitamin K given at birth 53, giving a survey population of 340. Forty general practitioners were identified as the preferred primary health care provider. There was a 100% questionnaire response rate. In the survey population the uptake of the third dose of vitamin K was 90.6%. (308 out of 340).

CONCLUSIONS

Further investigation is required to identify those infants not receiving the third oral dose and why. A more specific questionnaire requesting information as to why the third dose was omitted should have been designed. It may be necessary to consider the use of a single intramuscular dose of vitamin K to those breastfed infants who can be considered to have a high probability of not receiving the three oral doses of vitamin K within the first six weeks of life regardless of other risk factors.

摘要

目的

评估全科医疗中第三剂口服维生素K的摄取情况。

方法

确定1992年10月1日至1993年2月4日在罗托鲁瓦地区出生的婴儿。这包括在产科病房出生的所有婴儿以及罗托鲁瓦地区的家庭分娩婴儿。联系记录在案的首选初级医疗服务提供者——全科医生,并完成一份调查问卷。

结果

记录的出生人数为521例。其中104例因不住在罗托鲁瓦地区而被排除。在出生后居住在罗托鲁瓦的婴儿(417例)中,另有77例被排除,原因如下:未确定全科医生3例;死亡3例;转出——结果未知18例;出生时已注射维生素K 53例,最终调查人群为340例。确定了40名全科医生为首选初级医疗服务提供者。调查问卷的回复率为100%。在调查人群中,第三剂维生素K的摄取率为90.6%(340例中的308例)。

结论

需要进一步调查以确定那些未接受第三剂口服维生素K的婴儿及其原因。本应设计一份更具体的问卷,询问遗漏第三剂的原因。对于那些无论其他风险因素如何,在出生后头六周内极有可能未接受三剂口服维生素K的母乳喂养婴儿,可能有必要考虑使用单剂肌肉注射维生素K。

相似文献

1
The uptake of the third oral vitamin K dose in general practice.全科医疗中第三次口服维生素K剂量的摄取情况。
N Z Med J. 1994 May 11;107(977):177-8.
2
Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries.母乳喂养婴儿维生素K缺乏性出血的预防:来自荷兰和丹麦胆道闭锁登记处的经验教训。
Pediatrics. 2008 Apr;121(4):e857-63. doi: 10.1542/peds.2007-1788.
3
Vitamin K administration in neonates: survey of compliance with recommended practices in the Dunedin area.新生儿维生素K的使用:达尼丁地区推荐做法的依从性调查。
N Z Med J. 1995 Aug 25;108(1006):337-9.
4
Evaluation of the acceptability of a new oral vitamin K prophylaxis for breastfed infants.评估一种新的口服维生素 K 预防母乳喂养婴儿出血的可接受性。
Acta Paediatr. 2010 Mar;99(3):379-83. doi: 10.1111/j.1651-2227.2009.01630.x. Epub 2009 Dec 3.
5
Weekly oral vitamin K prophylaxis in Denmark.丹麦的每周口服维生素K预防措施。
Acta Paediatr. 2003 Jul;92(7):802-5.
6
Controversies surrounding the administration of vitamin K to newborns: a review.新生儿维生素K给药的争议:综述
CMAJ. 1996 Feb 1;154(3):307-15.
7
Vitamin K prophylaxis in the neonate by the oral route and its significance in reducing infant mortality and morbidity.新生儿口服维生素K预防及其在降低婴儿死亡率和发病率方面的意义。
J Med Assoc Thai. 1986 Oct;69 Suppl 2:56-61.
8
Vitamin K prophylaxis in the neonates by oral route with different dosages.通过口服不同剂量对新生儿进行维生素K预防。
J Med Assoc Thai. 1989 Jan;72 Suppl 1:125-9.
9
Administration of Vitamin K to newborns: implications and recommendations.给新生儿补充维生素K:影响与建议。
CMAJ. 1996 Feb 1;154(3):347-9.
10
[Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].[口服和肌内注射维生素K对60日龄以内新生儿的凝血因子II、VII、IX、X及异常凝血酶原II的影响]
Rev Med Chil. 2001 Oct;129(10):1121-9.

引用本文的文献

1
A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants.一种用于口服维生素K预防的新型混合胶束制剂:与母乳喂养婴儿的肌肉注射制剂进行随机对照比较。
Arch Dis Child. 1998 Oct;79(4):300-5. doi: 10.1136/adc.79.4.300.